Polyspecific snake antivenom may help in antivenom crisis
- 22 February 2003
- Vol. 326 (7386), 447a-447
- https://doi.org/10.1136/bmj.326.7386.447/a
Abstract
EDITOR—In Africa snakebites cause thousands of deaths annually and much permanent physical disability, but the supply of antivenom, the only specific treatment, is threatened by commercial pressures and privatisation. This has been caused over the past few years by the cessation of antivenom manufacture by Behringwerke in Germany, greatly reduced production by Aventis Pasteur in France, and the threat to continued production by Africa's sole remaining producer, the African Health Laboratory …This publication has 3 references indexed in Scilit:
- Crisis in snake antivenom supply for AfricaThe Lancet, 2000
- First Clinical Experiences with a New Ovine Fab Echis ocellatus Snake Bite Antivenom in Nigeria: Randomized Comparative Trial with Institute Pasteur Serum (Ipser) Africa AntivenomThe American Journal of Tropical Medicine and Hygiene, 1997
- Progress in the characterization of venoms and standardization of antivenoms.1981